255 related articles for article (PubMed ID: 18476672)
1. Salvinorin A analogs as probes in opioid pharmacology.
Prisinzano TE; Rothman RB
Chem Rev; 2008 May; 108(5):1732-43. PubMed ID: 18476672
[No Abstract] [Full Text] [Related]
2. A review of salvinorin analogs and their kappa-opioid receptor activity.
Roach JJ; Shenvi RA
Bioorg Med Chem Lett; 2018 May; 28(9):1436-1445. PubMed ID: 29615341
[TBL] [Abstract][Full Text] [Related]
3. Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa-opioid receptor.
Li Y; Husbands SM; Mahon MF; Traynor JR; Rowan MG
Chem Biodivers; 2007 Jul; 4(7):1586-93. PubMed ID: 17638340
[TBL] [Abstract][Full Text] [Related]
4. Chemical syntheses of the salvinorin chemotype of KOR agonist.
Hill SJ; Brion AUCM; Shenvi RA
Nat Prod Rep; 2020 Nov; 37(11):1478-1496. PubMed ID: 32808003
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of new salvinorin A analogues incorporating natural amino acids.
Fichna J; Lewellyn K; Yan F; Roth BL; Zjawiony JK
Bioorg Med Chem Lett; 2011 Jan; 21(1):160-3. PubMed ID: 21115248
[TBL] [Abstract][Full Text] [Related]
6. Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability.
Sherwood AM; Crowley RS; Paton KF; Biggerstaff A; Neuenswander B; Day VW; Kivell BM; Prisinzano TE
J Med Chem; 2017 May; 60(9):3866-3878. PubMed ID: 28376298
[TBL] [Abstract][Full Text] [Related]
7. Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Polepally PR; White K; Vardy E; Roth BL; Ferreira D; Zjawiony JK
Bioorg Med Chem Lett; 2013 May; 23(10):2860-2. PubMed ID: 23587424
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.
Lee DY; He M; Kondaveti L; Liu-Chen LY; Ma Z; Wang Y; Chen Y; Li JG; Beguin C; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2005 Oct; 15(19):4169-73. PubMed ID: 16051487
[TBL] [Abstract][Full Text] [Related]
9. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
[TBL] [Abstract][Full Text] [Related]
10. Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor.
Puls K; Wolber G
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677775
[TBL] [Abstract][Full Text] [Related]
11. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.
Placzek MS; Van de Bittner GC; Wey HY; Lukas SE; Hooker JM
Neuropsychopharmacology; 2015 Dec; 40(13):2865-72. PubMed ID: 26058662
[TBL] [Abstract][Full Text] [Related]
12. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Cunningham CW; Rothman RB; Prisinzano TE
Pharmacol Rev; 2011 Jun; 63(2):316-47. PubMed ID: 21444610
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
[TBL] [Abstract][Full Text] [Related]
14. Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.
Béguin C; Potuzak J; Xu W; Liu-Chen LY; Streicher JM; Groer CE; Bohn LM; Carlezon WA; Cohen BM
Bioorg Med Chem Lett; 2012 Jan; 22(2):1023-6. PubMed ID: 22204910
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of neoclerodane diterpenes and their pharmacological effects.
Lovell KM; Prevatt-Smith KM; Lozama A; Prisinzano TE
Top Curr Chem; 2011; 299():141-85. PubMed ID: 21630517
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A.
Lozama A; Cunningham CW; Caspers MJ; Douglas JT; Dersch CM; Rothman RB; Prisinzano TE
J Nat Prod; 2011 Apr; 74(4):718-26. PubMed ID: 21338114
[TBL] [Abstract][Full Text] [Related]
17. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
[TBL] [Abstract][Full Text] [Related]
18. Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide.
Chakraborty S; Majumdar S
Biochemistry; 2021 May; 60(18):1381-1400. PubMed ID: 32930582
[TBL] [Abstract][Full Text] [Related]
19. New opioid receptor modulators and agonists.
Kaye AD; Cornett EM; Patil SS; Gennuso SA; Colontonio MM; Latimer DR; Kaye AJ; Urman RD; Vadivelu N
Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):125-136. PubMed ID: 30322454
[TBL] [Abstract][Full Text] [Related]
20. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position.
Holden KG; Tidgewell K; Marquam A; Rothman RB; Navarro H; Prisinzano TE
Bioorg Med Chem Lett; 2007 Nov; 17(22):6111-5. PubMed ID: 17904842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
